Vote Scores
Filings read through

How funds voted at Bio-Rad Laboratories, Inc.

Ticker
BIO
SEC company number
12208
Filers reporting
595, year to 30 June 2026
Latest meeting on file
Meetings on file
3

In the year to 30 June 2026, 595 filers on Form N-PX reported votes at Bio-Rad Laboratories, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 1,284 marks to the ballot items, each with or against management. 79.4% of the marks are with management.

On say-on-pay, 54 of the 562 reporting filers that marked the item voted against management. This is 9.6% of the filers. Of the reported shares, 12.8% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

At the meeting of 21 Apr 2026, 43 fund families have a say-on-pay position with management and 5 have a position against management.

By filers reporting in the year to 30 June 2026, Bio-Rad Laboratories, Inc. was number 863 of 11,972 companies with a page and votes in that year. The number of filers reporting at Bio-Rad Laboratories, Inc. rose by 190.2% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category COMPENSATION is 20.2% of the vote records at Bio-Rad Laboratories, Inc.. At all companies on this site, it is 6.6%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 21 Apr 2026

594 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    2 nominees. 73.0% of the reported votes are for. 56 filers withheld from or voted against at least one nominee.

    784 vote records from 182 filers. 42 of the 180 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 44 fund families
    • For 35
    • Against 9
    • Against management 9
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    920 vote records from 589 filers. 54 of the 562 filers that marked the item voted against management. 27 filers gave no management mark.

    • Positions of 48 fund families
    • For 43
    • Against 5
    • Against management 5
  3. Item 3: Audit-related items (auditor ratification)

    391 vote records from 182 filers. 2 of the 180 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 44 fund families
    • For 44
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    418 vote records from 188 filers. 2 of the 185 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 44 fund families
    • For 44
  5. Item 5: Stockholder proposal regarding dual class capital structure.

    388 vote records from 179 filers. 165 of the 177 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 44 fund families
    • For 44
    • Against management 43

Positions of the fund families at the meeting of 21 Apr 2026

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

  • Proposal A: Stockholder proposal regarding dual class capital structure.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Bio-Rad Laboratories, Inc., meeting of 21 Apr 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-payProposal A
AllianceBernsteinForNo report
AllspringForFor, against management
American CenturyForFor, against management
BairdForNo report
BlackRock and iSharesForFor, against management
BNY MellonAgainst, against managementFor, against management
Brighthouse FundsForFor, against management
Capital Group and American FundsAgainst, against managementFor, against management
Charles SchwabForFor, against management
Columbia ThreadneedleForFor, against management
DimensionalForFor, against management
DWSForNo report
EquitableForFor, against management
Federated HermesForFor, against management
FidelityForFor, against management
First TrustForFor
Franklin TempletonForFor, against management
Goldman SachsForFor, against management
Guggenheim and RydexForFor, against management
Harbor FundsForFor, against management
InvescoAgainst, against managementFor, against management
J.P. MorganForFor, against management
Jackson National fundsAgainst, against managementFor, against management
John Hancock and ManulifeForFor, against management
Lincoln FinancialForFor, against management
MassMutualForFor, against management
MFSForFor, against management
Morgan Stanley, Eaton Vance and CalvertForFor, against management
NationwideForFor, against management
Natixis and Loomis SaylesForFor, against management
Neuberger BermanForNo report
Northern Trust and FlexSharesForFor, against management
Nuveen and TIAAForFor, against management
Pacific Life fundsForFor, against management
PGIM and PrudentialForFor, against management
PIMCOForFor, against management
PrincipalForFor, against management
ProShares and ProFundsForFor, against management
Russell InvestmentsForFor, against management
SEIForFor, against management
State Street and SPDRForFor, against management
T. Rowe PriceForFor, against management
ThriventForFor, against management
TransamericaForFor, against management
VanguardForFor, against management
Victory CapitalForFor, against management
VoyaForFor, against management
WisdomTreeAgainst, against managementFor, against management

Every meeting on file

Meetings of Bio-Rad Laboratories, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 202659459.6%
year to 30 June 2025205520.0%
year to 30 June 202423440.0%

Say-on-pay, season by season

Say-on-pay at Bio-Rad Laboratories, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 20265959.6%12.8%
year to 30 June 202520520.0%0.0%
year to 30 June 20242340.0%0.0%
Bio-Rad Laboratories, Inc. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management9.6%6.6%
Reported shares against management12.8%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Bio-Rad Laboratories, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS2,62139.9%
SECTION 14A SAY-ON-PAY VOTES93114.2%
AUDIT-RELATED1,30619.9%
SHAREHOLDER RIGHTS AND DEFENSES3885.9%
COMPENSATION1,32520.2%

The record at the SEC

Each link loaded on .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Cite this page

Vote Scores. How funds voted at Bio-Rad Laboratories, Inc.. https://votescores.com/company/bio-rad-laboratories-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Bio-Rad Laboratories, Inc. are on file?
3 meetings are on file, from 23 Apr 2024 to 21 Apr 2026. 3 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Bio-Rad Laboratories, Inc.?
Filers reported 1 proposal from security holders that the site could tell apart in the year to 30 June 2026. They fall in 1 meeting. The ballot on this page shows each proposal.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Bio-Rad Laboratories, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Bio-Rad Laboratories, Inc., grouped by company. The name is the most common spelling among filers. The ticker and the SEC company number come from the SEC company tickers file, matched on the exact name. The filers wrote the filings. Filings read through .